NSAID-exacerbated respiratory disease: a meta-analysis evaluating prevalence, mean provocative dose of aspirin and increased asthma morbidity (Q38412095)

From Wikidata

Jump to navigation Jump to search

scientific article published on 07 May 2015

Language	Label	Description	Also known as
English	NSAID-exacerbated respiratory disease: a meta-analysis evaluating prevalence, mean provocative dose of aspirin and increased asthma morbidity	scientific article published on 07 May 2015

Statements

scholarly article

1 reference

Europe PubMed Central

2 September 2017

0 references

1 reference

Europe PubMed Central

NSAID-exacerbated respiratory disease: a meta-analysis evaluating prevalence, mean provocative dose of aspirin and increased asthma morbidity (English)

1 reference

Europe PubMed Central

2 September 2017

1 reference

based on heuristic

inferred from title

respiratory disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25855099%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

author name string

D R Morales

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25855099%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

B J Lipworth

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25855099%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

C Jackson

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25855099%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

P T Donnan

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25855099%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

V H Santiago

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25855099%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

publication date

7 May 2015

1 reference

Europe PubMed Central

2 September 2017

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25855099%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

70

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25855099%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25855099%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

828-835

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25855099%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Trends in the use of aspirin and nonsteroidal anti-inflammatory drugs in the general U.S. population

1 reference

https://api.crossref.org/works/10.1111%2FALL.12629

21 January 2018

Aspirin therapy in primary cardiovascular disease prevention: a position paper of the European Society of Cardiology working group on thrombosis

1 reference

https://api.crossref.org/works/10.1111%2FALL.12629

21 January 2018

Primary and secondary prevention of cardiovascular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

1 reference

https://api.crossref.org/works/10.1111%2FALL.12629

21 January 2018

Estimates of benefits and harms of prophylactic use of aspirin in the general population

1 reference

https://api.crossref.org/works/10.1111%2FALL.12629

21 January 2018

Low-dose aspirin and cancer mortality: a meta-analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1111%2FALL.12629

21 January 2018

Increased levels of cysteinyl-leukotrienes in saliva, induced sputum, urine and blood from patients with aspirin-intolerant asthma.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12629

21 January 2018

Safety risks for patients with aspirin-exacerbated respiratory disease after acute exposure to selective nonsteroidal anti-inflammatory drugs and COX-2 inhibitors: Meta-analysis of controlled clinical trials

1 reference

https://api.crossref.org/works/10.1111%2FALL.12629

21 January 2018

Asthma death due to ibuprofen.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12629

21 January 2018

Rates of sensitivity reactions to aspirin: problems in interpreting the data

1 reference

https://api.crossref.org/works/10.1111%2FALL.12629

21 January 2018

EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity

1 reference

https://api.crossref.org/works/10.1111%2FALL.12629

21 January 2018

Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice

1 reference

https://api.crossref.org/works/10.1111%2FALL.12629

21 January 2018

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

1 reference

https://api.crossref.org/works/10.1111%2FALL.12629

21 January 2018

Estimating the mean and variance from the median, range, and the size of a sample

1 reference

https://api.crossref.org/works/10.1111%2FALL.12629

21 January 2018

Aspirin and tartrazine oral challenge: Incidence of adverse response in chronic childhood asthma

1 reference

https://api.crossref.org/works/10.1111%2FALL.12629

21 January 2018

Prevalence of aspirin-exacerbated respiratory disease in patients with asthma in Turkey: a cross-sectional survey.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12629

21 January 2018

Triggers in Intrinsic Asthma in the EGEA Study

1 reference

https://api.crossref.org/works/10.1111%2FALL.12629

21 January 2018

Aspirin-intolerant asthma in the population: prevalence and important determinants.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12629

21 January 2018

Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study

1 reference

https://api.crossref.org/works/10.1111%2FALL.12629

21 January 2018

Prevalence of asthma with aspirin hypersensitivity in the adult population of Poland

1 reference

https://api.crossref.org/works/10.1111%2FALL.12629

21 January 2018

Aspirin sensitivity and severity of asthma: evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthma

1 reference

https://api.crossref.org/works/10.1111%2FALL.12629

21 January 2018

Aspirin-intolerant asthma in the Korean population: prevalence and characteristics based on a questionnaire survey

1 reference

https://api.crossref.org/works/10.1111%2FALL.12629

21 January 2018

The prevalence of aspirin-induced asthma in Saudian asthmatic patients

1 reference

https://api.crossref.org/works/10.1111%2FALL.12629

21 January 2018

Major comorbid conditions in asthma and association with asthma-related hospitalizations and emergency department admissions in adults: results from the German National Health Telephone Interview Survey (GEDA) 2010.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12629

21 January 2018

The prevalence of aspirin intolerant asthma (AIA) in Australian asthmatic patients

1 reference

https://api.crossref.org/works/10.1111%2FALL.12629

21 January 2018

Safety of meloxicam in aspirin-hypersensitive patients with asthma and/or nasal polyps. A challenge-proven study

1 reference

https://api.crossref.org/works/10.1111%2FALL.12629

21 January 2018

Early effects of aspirin desensitization treatment in asthmatic patients with aspirin-exacerbated respiratory disease

1 reference

https://api.crossref.org/works/10.1111%2FALL.12629

21 January 2018

The Pivotal Role of 5-Lipoxygenase Products in the Reaction of Aspirin-sensitive Asthmatics to Aspirin

1 reference

https://api.crossref.org/works/10.1111%2FALL.12629

21 January 2018

Bronchial hyperreactivity to histamine in aspirin sensitive asthmatics: relationship to aspirin threshold and effect of aspirin desensitisation

1 reference

https://api.crossref.org/works/10.1111%2FALL.12629

21 January 2018

Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma

1 reference

https://api.crossref.org/works/10.1111%2FALL.12629

21 January 2018

Lack of cross-reactivity between rofecoxib and aspirin in aspirin-sensitive patients with asthma

1 reference

https://api.crossref.org/works/10.1111%2FALL.12629

21 January 2018

Safety of a specific COX-2 inhibitor in aspirin-induced asthma

1 reference

https://api.crossref.org/works/10.1111%2FALL.12629

21 January 2018

A prospective multicenter study of factors associated with hospital admission among adults with acute asthma

1 reference

https://api.crossref.org/works/10.1111%2FALL.12629

21 January 2018

The safety of celecoxib in patients with aspirin-sensitive asthma

1 reference

https://api.crossref.org/works/10.1111%2FALL.12629

21 January 2018

Safety of high-dose rofecoxib in patients with aspirin-exacerbated respiratory disease

1 reference

https://api.crossref.org/works/10.1111%2FALL.12629

21 January 2018

Improvements in an oral aspirin challenge protocol for the diagnosis of aspirin hypersensitivity

1 reference

https://api.crossref.org/works/10.1111%2FALL.12629

21 January 2018

Samter's triad in childhood: a warning for those prescribing NSAIDs.

1 reference

https://api.crossref.org/works/10.1111%2FALL.12629

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38412095&oldid=1758140062"